Lv3
238 积分 2021-07-29 加入
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials
2个月前
已完结
Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
2个月前
已完结
Lifitegrast ophthalmic solution 5.0% (KH732) for dry eye disease: A randomized, multicenter, double-masked, vehicle-controlled phase 3 trial
2个月前
已关闭
Full-field stimulus testing: Role in the clinic and as an outcome measure in clinical trials of severe childhood retinal disease
3个月前
已完结
Normal- and Low-Luminance Automated Quantitative Contrast Sensitivity Assessment in Eyes With Age-Related Macular Degeneration
3个月前
已完结
Ocular neuromodulation as a novel treatment for retinitis pigmentosa: identifying rod responders and predictors of visual improvement
3个月前
已关闭
Optogenetic Therapy With UGX-201 in Advanced Nonsyndromic Retinitis Pigmentosa: Safety and Efficacy From an Exploratory Clinical Trial
3个月前
已完结
Intravitreal photoswitch therapy in advanced retinitis pigmentosa: a phase 1 open-label trial
4个月前
已完结
Regulation of Retinal Microglia by Framework Nucleic Acid‐Mediated Delivery of microRNA‐124 Protects Retinal Ganglion Cells in Acute Glaucoma
4个月前
已完结
Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities
4个月前
已完结
皖公网安备34019202002308
